Skip to main content

Distinguished Speaker Series | Dr. Guilherme Testa Silva

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Brunson Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

October 9th, 2026 | Dr. Guilherme Testa Silva

Programming CNS cell types, connections and repair

 

Learn More About the Distinguished Speaker Series

Featured


Dr. Guilherme Testa Silva
Dr. Guilherme Testa Silva
  • Dr. Guilherme Testa Silva, Head of the Physiological Technologies group at the Institute of Molecular and Clinical Ophthalmology Basel (IOB), Switzerland

Guilherme Testa-Silva, Ph.D., is a vision scientist whose research focuses on understanding the cellular and physiological mechanisms underlying visual function and developing innovative approaches to restore sight. He serves as Head of Physiological Technologies at the Institute of Molecular and Clinical Ophthalmology Basel (IOB), where he leads interdisciplinary research combining physiological, molecular, and advanced imaging approaches to study the retina and visual system. His work investigates how retinal cells and visual circuits function and how alterations in these systems contribute to vision loss. Dr. Testa-Silva’s research has contributed to the development of technologies for studying retinal activity and exploring new strategies for vision restoration, including approaches that use engineered biological systems to enable light sensitivity in blind retinas. His laboratory aims to translate advances in visual physiology and technology into new therapeutic approaches that can restore sight and improve quality of life for individuals with vision loss.